论文部分内容阅读
贫血是慢性肾衰的严重并发症,其主要机理是红细胞生成素(EPO)缺乏。近来来,人工重组EPO应用于临床,使肾性贫血患者的贫血状况得到纠正,但仍有5％左右患者血色素(Hb)不升。现就其原因与诊治思路综述如下。1 EPO治疗肾性贫血时Hb不升的诊断标准据应用EPO的临床经验来看,肾性贫血患者对EPO的正常反应通常在治疗开始后第10天出现外周血网织红细胞计数的升高,随之出现Hb、红细
Anemia is a serious complication of chronic renal failure, the main mechanism is the lack of erythropoietin (EPO). Recently, artificial reorganization of EPO used in clinical patients with anemia of anemia have been corrected, but still about 5% of patients with hemoglobin (Hb) does not rise. Now its reason and diagnosis and treatment ideas are summarized below. 1 EPO treatment of renal anemia Hb does not rise the diagnostic criteria According to the clinical experience of the use of EPO, renal anemia patients with normal response to EPO usually appear in the treatment of 10 days after the start of peripheral blood reticulocyte count increased, Appear Hb, red fine